Biolase Inc (BIOL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BIOL Annual Balance Sheets →
The table below presents a historical view of Biolase Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent3.44
Cash & Short-term Investments3.00
Accounts receivable3.53
Inventories9.87
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.58
Total Current Assets19.43
Equipment/Property/Plant Net3.66
Goodwill net2.93
Other Assets, Noncurrent1.23
Operating Lease Right Of Use Asset0.97
Total Assets27.24
Liabilities
Accounts Payable, Current AC3.00
Accrued Liabilities, Current AC8.15
Medium-term Notes, Current ME16.04
Deferred Revenue, Current DE2.23
Total Current Liabilities30.86
Long-term debt0.00
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.22
Other liabilities, Noncurrent1.04
Stock Warrant Liability1.44
Operating Lease Liability Noncurrent0.21
Total Liabilities32.12
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock322.78
Retained Earnings / Accumulated Deficit-327.51
Other Equity-0.88
Common Stockholder's Equity-5.57
Non-controlling interests & other0.35
Total Stockholder's Equity-5.23
Liabilities & Stockholder's Equity27.24
4 historic quarters locked

Sign in to unlock the full Biolase Inc balance sheet history.

About Biolase Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-123472

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.